Bellevue Group Ag Horizon Therapeutics Public LTD CO Transaction History

Bellevue Group Ag

$6.38 Billion
Q1 2024

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	SELL	$62.39 - $113.8 $18.1 Million - $32.9 Million	-289,439 Reduced 95.89%	12,411 $1.41 Million
Q3 2022 Nov 14, 2022	SELL	$58.92 - $84.67 $2.1 Million - $3.01 Million	-35,584 Reduced 10.55%	301,850 $18.7 Million
Q2 2022 Aug 11, 2022	SELL	$79.4 - $116.36 $608,680 - $892,015	-7,666 Reduced 2.22%	337,434 $26.9 Million
Q1 2022 May 13, 2022	SELL	$86.42 - $109.81 $2.03 Million - $2.58 Million	-23,500 Reduced 6.38%	345,100 $36.3 Million
Q4 2021 Feb 10, 2022	SELL	$98.56 - $119.91 $4.69 Million - $5.71 Million	-47,600 Reduced 11.44%	368,600 $39.7 Million

Q3 2021 Nov 12, 2021	SELL	$91.91 - $110.37 $137,865 - $165,555	-1,500 Reduced 0.36%	416,200 $45.6 Million
Q2 2021 Aug 12, 2021	BUY	$86.24 - $95.92 $793,408 - $882,464	9,200 Added 2.25%	417,700 $39.1 Million
Q1 2021 May 12, 2021	BUY	$71.83 - $95.48 $2.03 Million - $2.7 Million	28,300 Added 7.44%	408,500 $37.6 Million
Q4 2020 Feb 16, 2021	BUY	$67.0 - $84.39 $20.3 Million - $25.6 Million	302,800 Added 391.21%	380,200 $27.8 Million
Q3 2020 Nov 16, 2020	SELL	$55.23 - $79.93 $4.46 Million - $6.46 Million	-80,800 Reduced 51.07%	77,400 $6.01 Million
Q2 2020 Aug 13, 2020	SELL	$30.2 - $56.98 $235,560 - $444,444	-7,800 Reduced 4.7%	158,200 $8.79 Million
Q1 2020 May 14, 2020	SELL	$24.87 - $38.56 $3.72 Million - $5.77 Million	-149,700 Reduced 47.42%	166,000 $4.92 Million
Q4 2019 Feb 14, 2020	SELL	$25.43 - $36.67 $193,268 - $278,692	-7,600 Reduced 2.35%	315,700 $11.4 Million
Q3 2019 Nov 14, 2019	BUY	$23.0 - $27.97 $1.26 Million - $1.53 Million	54,800 Added 20.41%	323,300 $8.8 Million
Q2 2019 Aug 14, 2019	BUY	$22.81 - $28.48 $6.12 Million - $7.65 Million	268,500 New	268,500 $6.46 Million

Others Institutions Holding HZNP

# of Institutions

Shares Held

2.07M

Call Options Held

Put Options Held

20K

View Full List

About Horizon Therapeutics Public Ltd Co

Ticker HZNP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 230,384,000
Description
Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...

More about HZNP

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bellevue Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Bellevue Group Ag with notifications on news.

Account